AstraZeneca starts Phase III program for asthma drug tralokinumab – Pharmaceutical Business Review

AstraZeneca starts Phase III program for asthma drug tralokinumab
Pharmaceutical Business Review
AstraZeneca has started the Phase III program for an investigational human monoclonal antibody tralokinumab, a potential treatment for patients with severe, inadequately controlled asthma, developed by the company's global biologics research and …

View full post on asthma – Google News

NH Receives $500K Grant for Asthma Control Program – My Champlain Valley FOX44 & ABC22


My Champlain Valley FOX44 & ABC22

NH Receives $500K Grant for Asthma Control Program
My Champlain Valley FOX44 & ABC22
“As founder and co-chair of the bipartisan Congressional Asthma and Allergy Caucus, I'm acutely aware that asthma is a significant public health challenge facing New Hampshire and our nation, but it can be managed through better treatment and education

View full post on asthma – Google News